Search

everythinglearnresearchcommunity

for

Search:↓

Lower LDL-c levels predict higher COVID-19 mortality.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The model and estimator can predict drug exposure in kidney transplant patients well.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Long-COVID has diverse, long-term health impacts, especially in young people.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

High-dose methotrexate can cause severe skin and nail issues.

Age, health conditions, race, and gender affect COVID-19 risk.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Bicalutamide may help treat female pattern hair loss.

mTOR inhibitors may help treat lung fibrosis.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.